FABHALTA® from Novartis
For IgA nephropathy (IgAN) & C3 glomerulopathy (C3G) • DSE Campaign (DTC & HCP)
DTC DSE Website
Built kidneyhope.com from the ground up—defining information architecture and core messaging across two rare renal indications. Navigated a midstream platform pivot requiring full structural revision while preserving clarity and strategic balance.
Workplace Tips Guide
Authored a lifestyle-focused resource for people living with rare kidney disease—researching ADA, FMLA, and workplace accommodation guidance to create an empowering tool that extends beyond clinical education and addresses real-world patient needs.
HCP Conference Tabletop Display
Shaped messaging architecture for a tri-fold HCP display unifying two mechanistically distinct rare renal diseases within a constrained physical format. Collaborated closely with medical partners to distill complex pathophysiology into clear, rigorous, and visually cohesive disease education.
Future Platform Exploration
Contributed to early branded concept exploration as FABHALTA prepared to transition from DSE to a fully branded campaign. Co-developed scalable visual metaphors and platform-level narratives designed to unify multiple renal indications through bold, emotionally resonant storytelling.
